A record-high $1.6bn of non-life ILS capacity was issued in the third quarter of 2018, as enthusiasm for alternative capital continued for ILS amongst both issuers and investors.
For details on how to subscribe or for all commercial opportunities, including advertising, please contact:
Tel: +44 (0) 203 934 6687
Tel: +44 (0) 203 934 6684
Subscribers get access to: